🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to verify if adding a locoregional treatment o...
Status
Terminated
Location
Albano Laziale Ospedale "Regina Apoltolorum"
Start Date
2013-07
Trial ID
NCT01755182
Treatments Being Tested
The phase I/II, double-blind, randomized study will investigate the efficac...
Status
Terminated
Location
Kaohsiung Veterans General Hospital
Start Date
2022-09-13
Trial ID
NCT05435014
This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-08-27
Trial ID
NCT03457948
This phase 1 study is to determine the optimal dose and tolerability of a h...
Status
Recruiting
Location
Stanford University
Start Date
2014-09
Trial ID
NCT02174549
Treatments Being Tested
This prospective, single-arm exploratory study evaluates the feasibility an...
Status
Recruiting
Location
West China Hospital
Start Date
2026-01-01
Trial ID
NCT07295262
Treatments Being Tested
This Phase I/II trial aims to evaluate the pharmacokinetics, efficacy, and ...
Status
Terminated
Location
The First Affiliated Hospital of Soochow University
Start Date
2021-05-14
Trial ID
NCT06848556
Treatments Being Tested
Patients with unresectable hepatocellular carcinoma will receive hepatic ar...
Status
Completed
Location
Guangxi Medical University Cancer Hospital
Start Date
2022-11-10
Trial ID
NCT05532319
Treatments Being Tested
NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the...
Status
Completed
Location
CHU de Saint-Etienne
Start Date
2024-03-01
Trial ID
NCT06301919
Treatments Being Tested
This study intends to evaluate the efficacy and safety of Transarterial emb...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-05
Trial ID
NCT02964260
Treatments Being Tested
This study evaluates the addition of nivolumab to TACE/TAE in the treatment...
Status
Suspended
Location
Unicancer
Start Date
2019-05-08
Trial ID
NCT04268888
Treatments Being Tested